DavidMFleischerMD

Pediatric Asthma & Allergic Conditions

Professor of Pediatrics and Section Head, Children's Hospital Colorado, University of Colorado Denver School of Medicine

Dr. Fleischer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

Pharmacokinetic and Pharmacodynamic Profile of Epinephrine Nasal Spray Versus Intramuscular Epinephrine Autoinjector in Healthy Adults.
Matthew Greenhawt, Jay Lieberman, Michael Blaiss, David I Bernstein, John Oppenheimer
The Journal of Allergy and Clinical Immunology. in Practice. 2024-12-01
10 practical priorities to prevent and manage serious allergic reactions: GALEN ANACare and EFA Anaphylaxis Manifesto.
Antonella Muraro, Debra de Silva, Marcia Podesta, Aikaterini Anagnostou, Victoria Cardona
Clinical and Translational Allergy. 2024-12-01
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the A...
Aikaterini Anagnostou, J Andrew Bird, Sharon Chinthrajah, Timothy E Dribin, David M Fleischer
The Journal of Allergy and Clinical Immunology. 2024-11-22

Journal Articles

Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy Therapies
Matthew Greenhawt, Marcus Shaker, Don A Bukstein, David M Fleischer, David R Stukus, Annals of Allergy, Asthma & Immunology
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy
Todd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA

Other

A Possible New Way to Treat Peanut Allergy
David Fleischer, MD, Scientific American
https://www.doximity.com/articles/0d399fab-691d-4f64-b35a-71dfe377e728
UpToDate, Wolters Kluwer Health - 2012-11-01
Managing Cross-Reactivity in Those with Peanut Allergy
David Fleischer, MD, ScienceDirect
https://www.doximity.com/articles/cc57bc03-a20f-47e7-a66e-5a1af2746d99
UpToDate, Wolters Kluwer Health - 2012-06-12
Managing Cross-Reactivity in Those with Peanut Allergy
David Fleischer, MD, ScienceDirect
https://www.doximity.com/articles/cc57bc03-a20f-47e7-a66e-5a1af2746d99
UpToDate, Wolters Kluwer Health - 2013-04-01

Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesFebruary 2020

Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE StudiesAugust 22nd, 2020
Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy: The PEPITES Randomized Clinical TrialMarch 12th, 2020
DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020February 24th, 2020
Join now to see all